Palforzia Will Be a New Treatment for Peanut Allergy

January 2021

You'll see Palforzia used as the first FDA-approved treatment for peanut allergy.

Palforzia is a peanut allergen powder given orally to allergic patients 4 to 17 years old. The goal is to decrease sensitivity to small amounts of peanuts...by slowly increasing exposure.

Palforzia doesn't allow patients to freely eat peanut products. But it may minimize an allergic reaction from accidental exposure.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote